Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01923389
What this trial is testing

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Pfizer 4
Not applicableLooking for participantsNCT06469437
What this trial is testing

The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

Who this might be right for
Type2diabetesFrail Elderly SyndromeFrailty+1 more
Hospital de Clinicas de Porto Alegre 220
Early research (Phase 1)Looking for participantsNCT07803809
What this trial is testing

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

Who this might be right for
Overweight , ObesityType 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd 36
Testing effectiveness (Phase 2)Study completedNCT01889667
What this trial is testing

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus Type 2
Oramed, Ltd. 30
Not applicableWithdrawnNCT01850134
What this trial is testing

Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.

Who this might be right for
Diabetes
Abbott Nutrition
Early research (Phase 1)Study completedNCT02759107
What this trial is testing

Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Who this might be right for
HealthyType 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company 142
Large-scale testing (Phase 3)Looking for participantsNCT07394114
What this trial is testing

HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 240
Early research (Phase 1)Study completedNCT01794364
What this trial is testing

Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects

Who this might be right for
Healthy
Pfizer 8
Not applicableStudy completedNCT04383314
What this trial is testing

Targeting Hyaluronan Accumulation Through Exercise in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
NYU Langone Health 30
Not applicableStudy completedNCT06602778
What this trial is testing

Physical Activity Level and Sleep Quality in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)SleepBiomarkers / Blood+1 more
Selcuk University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT06858878
What this trial is testing

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Who this might be right for
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Amgen 1,105
Not applicableActive Not RecruitingNCT06445335
What this trial is testing

Prevalence of NAFLD in T2DM Patients

Who this might be right for
NAFLDT2DType 2 Diabetes+1 more
Ziekenhuis Oost-Limburg 385
Post-approval studies (Phase 4)Study completedNCT00979628
What this trial is testing

Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 DiabetesHyperglycemia
Guillermo Umpierrez, MD 375
Not applicableNot Yet RecruitingNCT06674161
What this trial is testing

The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and Future

Who this might be right for
Mortality of Patients with CVDMortality of Patients with CVD and T2DMMortality of Patients with T2DM+4 more
King Faisal Specialist Hospital & Research Center 80
Testing effectiveness (Phase 2)Study completedNCT01804842
What this trial is testing

Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Elcelyx Therapeutics, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT03645421
What this trial is testing

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 61
Testing effectiveness (Phase 2)Study completedNCT00856908
What this trial is testing

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

Who this might be right for
Type II Diabetes
AstraZeneca 20
Post-approval studies (Phase 4)Study completedNCT01196546
What this trial is testing

Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Novartis 161
Large-scale testing (Phase 3)Study completedNCT04304261
What this trial is testing

Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

Who this might be right for
Diabetes Mellitus, Type 2Cognitive Functions Confusion
Third Military Medical University 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07667517
What this trial is testing

Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
AlbuminuriaType 2 Diabetes Mellitus (T2DM)Chronic Kidney Diseases
First Affiliated Hospital of Zhejiang University 148
Next Page